Jinyu Bio-Technology Co

Jinyu Bio-Technology Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jinyu Bio-Technology Co (600201.SS) as of Oct 27, 2026 is 119.75 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 208.32 M CNY — a change of -42.52% (lower).

EBITDA

119.75 MCNY

YoY

-42.52%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jinyu Bio-Technology Co is 2025 119.75 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jinyu Bio-Technology Co was 2024 208.32 M CNY. It decreases by -42.52% lower compared to the previous year.

The Jinyu Bio-Technology Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
928.74 M CNY
Jan 1, 2019
307.11 M CNY
Jan 1, 2020
561.15 M CNY
Jan 1, 2021
509.79 M CNY
Jan 1, 2022
333.58 M CNY
Jan 1, 2023
372.35 M CNY
Jan 1, 2024
208.32 M CNY
Jan 1, 2025
119.75 M CNY
The Jinyu Bio-Technology Co EBITDA history
YEAREBITDAYoY
119.75 MCNY-42.52%
208.32 MCNY-44.05%
372.35 MCNY+11.62%
333.58 MCNY-34.57%
509.79 MCNY-9.15%
561.15 MCNY+82.72%
307.11 MCNY-66.93%
928.74 MCNY-10.01%
1.03 BCNY+32.42%
779.33 MCNY+28.83%
604.92 MCNY+23.78%
488.71 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jinyu Bio-Technology Co is 119.75 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jinyu Bio-Technology Co changed from 208.32 M CNY to 119.75 M CNY, representing a -42.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Jinyu Bio-Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Jinyu Bio-Technology Co

All Key Metrics — Jinyu Bio-Technology Co